Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
This keeps the scalp tissue "pliable" and healthy for hair production
Exendin-4 (exenatide) became the first clinically-approved GLP-1R agonist (2005) for treatment of T2D
In this theory, reduced amounts of IGF-1 bioavailability would impact sebocyte proliferation via the loss of regulatory functions that IGF-1 has on 5-Reductase, while also causing impaired processing of secreted lipids in the interfollicular epidermis, which combined could result in the eventual keratinization of both the sebaceous gland and the impaired epithelial barrier of the follicular canal
Physician-formulated digestive enzyme for GLP-1 medication users
US$ 28.47
US$ 23.07
US$ 28.55
US$ 25.72
US$ 21.41
